EUROPEAN stocks rose for a second week, led by technology companies and drug makers, after Ericsson AB and Bayer AG reported better-than-estimated earnings and UCB SA won United States approval for a new Crohn's disease medicine.
UK pub companies and home builders limited gains as Punch Taverns Plc reported a drop in profit and Persimmon Plc postponed work on new sites. ProSiebenSat.1 Media AG led a retreat by media shares after the German broadcaster saw lower profit.
The Dow Jones Stoxx 600 Index added 0.3 percent to 321.7, extending the 3.2-percent rise two weeks ago. The index has fallen 12 percent this year on concern more than US$290 billion in losses related to the collapse of the US subprime-mortgage market will drag down global economic growth, Bloomberg News said.